Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-12-041179
Filing Date
2012-08-10
Accepted
2012-08-10 06:00:45
Documents
1
Period of Report
2012-08-11

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c29636_3x0.html 3  
1 MAIN DOCUMENT DESCRIPTION c29636_3x0.xml 3 3018
  Complete submission text file 0001209191-12-041179.txt   4782
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Reporting) CIK: 0001121404 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-54735 | Film No.: 121022459
SIC: 2834 Pharmaceutical Preparations

Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations